Bringing you the latest cutting-edge research and commentary in bioscience.

Cell & Gene Therapy Insights

Cell & Gene Therapy Insights

Issue Vol 4 Suppl. 1

Interview

Meeting the Demand: Next-Generation Viral Vectors for Gene Therapy

Spotlight Article

Interview

Anc-80: latest updates on the novel Anc-AAV gene therapy vector

Interview Ryan Scanlon Anc-80: latest updates on the novel Anc-AAV gene therapy vector RYAN SCANLON has been the commercial leader for Lonza’s viral gene therapy business since 2013, where he has been instrumental in shaping Lonza’s gene therapy strategy by driving the business case for the recent relocation and expansion of the new Lonza Houston […]

Read full article »

Flexible, Modular Manufacturing to Address Viral Vector Capacity Bottlenecks

Spotlight Article

Interview

Anc-80: latest updates on the novel Anc-AAV gene therapy vector

The sector has been experiencing tremendous growth and investment – what have been the standout moments for you thus far? XS: I think the excitement around developments in the cell and gene therapy space has been building for the last 20 years, but last year’s approval of the two CAR T- programs – and also […]

Read full article »

Addressing the Limitations of AAV Vectors through Evolutionary Guided Vector Design

Spotlight Article

Interview

Anc-80: latest updates on the novel Anc-AAV gene therapy vector

Interview LUK H VANDENBERGHE Anc-80: latest updates on the novel Anc-AAV gene therapy vector LUK H VANDENBERGHE, PHD, is an Assistant Professor at Harvard Medical School and Associate Member of the Broad Institute of Harvard and MIT in Boston, MA, USA. He directs the Grousbeck Gene Therapy Center at Massachusetts Eye and Ear Infirmary in […]

Read full article »
Research Article

Establishment of a scalable manufacturing platform for in-silico-derived ancestral adeno-associated virus vectors

Spotlight Article

Research Article

Anc-80: latest updates on the novel Anc-AAV gene therapy vector

RESEARCH ARTICLE Anc-80: latest updates on the novel Anc-AAV gene therapy vectoR Bingnan Gu, Vijetha Bhat, Wenling Dong, Hai Pham, Stephanie Pubill, Nagarjun Kasaraneni, Eric Onishi, Francesca Vitelli & Anandita Seth Adeno-associated virus (AAV) is an effective viral vector for gene therapy due to its non-pathogenicity, high transduction efficiency, broad tissue specificity and long-term transgene […]

Read full article »
Twitter IconVisit Our Blog